1 / 34

Postpartum Hemorrhage (PPH)

Postpartum Hemorrhage (PPH). Family Medicine Specialist CME University of Health Sciences. Clinical Case.

dtant
Download Presentation

Postpartum Hemorrhage (PPH)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Postpartum Hemorrhage(PPH) Family Medicine Specialist CME University of Health Sciences

  2. Clinical Case 25 year-old G7P2 female presents for delivery, which occurs very rapidly after arriving at the District Hospital. Her baby was delivered without difficulty but then the placenta was retained and she began to hemorrhage. What is your definition of a postpartum hemorrhage? What are the risk factors this patient has for a postpartum hemorrhage? What are you going to do to manage this patient?

  3. Objectives • Define postpartum hemorrhage (PPH) • Discuss the risk factors and possible causes for PPH • Describe the preventative measures to take to prevent a PPH • Discuss the management of PPH • Explain the risks to maternal morbidity and mortality of PPH

  4. Definitions • Primary/immediate PPH • Excessive bleeding during the 24 hours after a delivery • Most often due to uterine atony • Secondary/late PPH • Excessive bleeding between 24 hours and up to 6 weeks after delivery • Most often due to retain products of conception, infection or both

  5. What is excessive bleeding or a PPH? • Vaginal delivery • >500 cc of blood loss • Cesarean section • >1000 cc of blood loss • Clinically • Any blood loss that causes the patient to be hemodynamically unstable

  6. Hypovolemia Clinical Presentation • Moderate (20–40% of blood volume) • Heart rate - >110 bpm • Tachycardia - >30 rpm • BP – Normal in supine position/significant postural hypotension • Skin - marked pallor; conjuntiva, palms and mucous • Neurologic status – increasingly anxious Mild (<20% of blood volume) • Heart rate - mild tachycardia • Skin – mottled, cool extremities due to increased systemic vascular resistance and prolonged capillary refilling • Urinary output - decreased • Neurologic status – may report dizziness but usually remains normal Severe (>40% of blood volume) • Heart rate - marked tachycardia • BP – declines/unstable even in supine position • oliguria or anuria • Neurologic status – agitation, confusion, possible loss of consciousness

  7. Estimating blood loss • Usually underestimated • Ongoing trickling can cause significant blood loss • Underestimation can lead to delayed or inadequate treatment • If patient is anemic, then the ability to compensate for blood loss may not be possible and patient cannot tolerate any blood loss

  8. PPH Etiology • Tone – uterine atony • Tissue – retained placenta • Trauma – vaginal/cervical lacerations, rupture, inversion of uterus • Thrombin - coagulopathy

  9. Tone: Risk Factors Etiologic processClinical risk factors Overdistended uterus Polyhydramnios Multiple gestation Macrosomia Uterine muscle Rapid labour exhaustion Prolonged labour High parity Intraamniotic infection Fever Prolonged rupture of membranes (PROM)

  10. Tone – Risk Factors (2) Etiologic processClinical risk factors Functional or anatomic Fibroid uterus distortion of the uterus Placenta previa or abruptio Uterine anomalies Uterine-relaxing Halogenated medications anesthetics nitroglycerin, magnesium sulphate

  11. Tissue – Risk FactorsRetained Placental tissue Etiologic process Clinical risk factors Retained products, Incomplete delivery of placenta abnormal placentation, Previous uterine surgery retained cotyledon or High Parity succinuriate lobe Abnormal placenta on ultrasound Retained blood clotsAtonic uterus

  12. Trauma (Genital Tract) – Risk Factors Etiologic processClinical risk factors Tears (lacerations) of the Precipitous delivery cervix, vagina, or perineum Operative delivery Ruptured vulvar varicosities Mistimed or inappropriate use of episiotomy Extensions, lacerations Malposition at cesarean section Deep engagement Uterine rupturePrevious uterine surgery Uterine inversion High parity Fundal placenta

  13. Thrombin (Abnormalities of Coagulation) – Risk Factors Etiologic processClinical risk factors Pre-existing states History of hereditary coagulopathies History of liver disease Therapeutic History of thrombotic anticoagulation disease

  14. Thrombin (Abnormalities of Coagulation) – Risk Factors (2) Etiologic processClinical risk factors States acquired in pregnancy • idiopathic thrombocytopenic bruising purpura elevated blood pressure • thrombocytopenia with fetal demise preeclampsia fever • disseminated intravascular elevated white blood cells coagulation antepartum hemorrhage • preeclampsia sudden collapse • dead fetus in utero • severe infection/sepsis • placental abruption • amniotic fluid embolus

  15. Prevention of PPH – Active Management of the Third Stage of Labor • prophylactic administration of oxytocin with delivery of anterior shoulder or immediately after delivery • 10 U IM OR 5 U IV bolus • clamp and cut cord after pulsating has stopped • palpate the uterine fundus and confirm the uterus is contracted • perform controlled cord traction with suprapubic counter traction with next strong contraction • perform uterine massage after delivery of the placenta, as appropriate • examine placenta for completeness

  16. Controlled cord Traction

  17. Uterotonics - Oxytocin • stimulates smooth muscle tissue of the upper segment of the uterus causing it to contract rhythmically, constricting blood vessels, and decreasing blood • safe and effective first choice for prevention and treatment • acts almost immediately for IV injections, and within 3 to 5 minutes for IM injections • should be stored in a cool, dry place • uncommon side effects: nausea, vomiting, and headache

  18. Uterotonics – Ergot Alkaloids “Ergometrine” • causes the smooth muscle of both the upper and lower uterus to contract tetanically • takes 5 to 7 minutes to take effect when given intramuscularly • effects last approximately 2 to 4 hours • should be stored in a refrigerator between 2°C – 8°C and away from light • adverse effects include nausea and vomiting

  19. Uterotonics – Prostaglandins “Misoprostol” • causes vasoconstriction and enhances contractibility of the uterine muscles • administered orally or sublingually (rapid action), or rectally (acts fir greater period of time) for prevention or treatment of PPH • relatively inexpensive, easy to store, stable at room temperature • side effects: shivering and fever are generally mild

  20. Management of Postpartum Hemorrhage • Prevention is the key! • Identify and manage risk factors identified for potential PPH • Active management of the third stage of labor

  21. Management of Postpartum Hemorrhage • Active management of the Third Stage of Labor • REMEMBER the ABCs • Call for HELP • Estimate blood loss. • Ask the woman to urinate or catheterize • Put the baby to the breast • Give Oxygen • Assess the uterus using external or internal bimanual massage • Give uterotonic - Oxytocin, Misoprostol, ergotamine • Observe the woman, and consider transport if unstable or bleeding continues

  22. Management of PPH ABC A = airway B = breathing C = circulation

  23. External Bimanual Uterine Massage

  24. Internal Bimanual Uterine Massage

  25. Examine the placenta for completeness Examination of fetal side Examination of maternal side

  26. Manual removal of placenta 1. 2. 3. 4.

  27. Management of Postpartum Hemorrhage • Examine the genitals for trauma and repair as required ie. vulva, vagina, cervix • If bleeding continues may require uterine tamponade or aortic compression • Ensure no uterine inversion or rupture • Manage possible coagulopathy with blood transfusion (if possible) • Consider transfer to facility for surgical management of PPH

  28. Aortic Compression

  29. Uterine Tamponade

  30. Management of secondary PPH Associated with: • retained placental fragments or membranes • infection • shedding of dead tissue following an obstructed labour • breakdown of a uterine wound after a cesarean section or ruptured uterus

  31. Management of secondary PPH (2) • assess the woman’s condition carefully • control blood loss • treat for shock, if necessary • administer antibiotics prophylactically for infection • provide anti-tetanus prophylaxis, if necessary • if there is no improvement with the above treatments, refer the woman promptly for further assessment and treatment

  32. Continued care of woman Once the bleeding is controlled, and the woman is stable, careful monitoring over the next 24–48 hours is required, including: • monitoring uterine tone • monitoring vital signs • estimating ongoing blood loss • ensuring adequate fluid intake • monitoring blood transfusions • monitoring urinary output • ensuring the continuous presence of a skilled attendant, who maintains good documentation

  33. Before discharge from hospital • check hemoglobin, and provide supplements as required • examine for hookworm infestation, malaria, HIV/AIDS or other co-existing conditions, provide treatmentas required • provide the mother and her family with information about her experience of PPH • ensure that lactation has been established, and that a well baby care plan is in place

  34. Conclusion • Assess patient for PPH risk factors and manage accordingly • Prevention is the key: Active management of the third stage of labor • Management of bleeding is essential for saving a woman’s life • Refer to center as required for advanced care

More Related